Terms: = Uterine cancer AND PR, PGR, progesterone receptor
2263 results:
1. Protective effect of quercetin on lipopolysaccharide‑induced miscarriage based on animal experiments and network pharmacology.
Wu S; Tian Y; Zhang Q; Fu Z; Lan H; Zhou X; Ma L; Lou Y
Mol Med Rep; 2024 Jun; 29(6):. PubMed ID: 38606505
[TBL] [Abstract] [Full Text] [Related]
2. Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study.
Tuninetti V; Virano E; Salutari V; Ricotti A; Pisano C; Ducceschi M; Turitto G; Scandurra G; Petrella MC; Forestieri V; Rizzetto M; Mammoliti S; Artioli G; Cioffi R; Borsotti L; Bellero M; Rognone C; Carbone V; Ferrandina G; Mantiero M; Azzolina C; Geninatti E; Pignata S; Valabrega G
Eur J Cancer; 2024 May; 203():114039. PubMed ID: 38598922
[TBL] [Abstract] [Full Text] [Related]
3. Human Papillomavirus Vaccine Awareness and Acceptability for Primary Prevention of Cervical cancer in Pakistan: A Cross-Sectional Study.
Shamsi U; Zahid F; Abdul Jabbar AB; Musharraf MD; Gauhar F; Akbar I; Sherwani M; Bhatti WK; Chaudhary EUH; Sadiq S; Shaikh AN; Shaikh F
Asian Pac J Cancer Prev; 2024 Mar; 25(3):813-820. PubMed ID: 38546064
[TBL] [Abstract] [Full Text] [Related]
4. Impaired fertility in adenomyosis: a murine model reveals endometrial receptivity and progesterone resistance imbalances.
Squatrito M; Vervier J; Bindels J; Bernet L; Blacher S; Nisolle M; Munaut C
Reproduction; 2024 May; 167(5):. PubMed ID: 38451875
[TBL] [Abstract] [Full Text] [Related]
5. To study the expression of estrogen, progesterone receptor and p53 immunohistochemistry markers in subtyping endometrial carcinoma.
Yadav A; Sistla A; Swain M; Gowrishankar S; Padua M; Modi T; Himabindu R; Agarwal N; Kulkarni A; Bhandari T; Vudayaraju H; Chinnababu ; Reddy VA
Indian J Pathol Microbiol; 2024; 67(1):62-67. PubMed ID: 38358190
[TBL] [Abstract] [Full Text] [Related]
6. Trichorhinophalangeal Syndrome Type 1 Immunohistochemical Expression in Carcinomas of Gynecologic Origin.
Ruiz F; Tjendra Y; Millan N; Gomez-Fernandez C; Pinto A
Am J Surg Pathol; 2024 May; 48(5):546-550. PubMed ID: 38357982
[TBL] [Abstract] [Full Text] [Related]
7. Factors associated with utilization of cervical cancer screening services among HIV-positive women aged 18 to 49 years at Lira regional referral hospital, Northern Uganda.
Layet F; Murungi T; Ashaba N; Kigongo E; Opollo MS
BMC Womens Health; 2024 Feb; 24(1):114. PubMed ID: 38347497
[TBL] [Abstract] [Full Text] [Related]
8. The management of uterine tumor resembling an ovarian sex cord tumor (UTROSCT): case series and literature review.
Lin J; Liu L; Wang L; Ma N; Zhang K; Xie N; Yu H; Deng S; Sun Y
World J Surg Oncol; 2024 Feb; 22(1):42. PubMed ID: 38310233
[TBL] [Abstract] [Full Text] [Related]
9. Rare germline mutation and MSH2-&MSH6 + expression in a double primary carcinoma of colorectal carcinoma and endometrial carcinoma: a case report.
Zhang T; Huang X; Liu W; Ling X; Su Z; Huang M; Che S
Diagn Pathol; 2024 Jan; 19(1):25. PubMed ID: 38297350
[TBL] [Abstract] [Full Text] [Related]
10. A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRα-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer, or triple negative breast cancer.
Cristea MC; Stewart D; Synold T; Ruel N; Mortimer J; Wang E; Jung A; Wilczynski S; Konecny GE; Eng M; Kilpatrick L; Han E; Dellinger T; Hakim A; Lee S; Morgan RJ; Wakabayashi MT; Frankel PH
Gynecol Oncol; 2024 Mar; 182():124-131. PubMed ID: 38262235
[TBL] [Abstract] [Full Text] [Related]
11. The comparison of pure uterine serous carcinoma and mixed tumor with serous component: a single-institution review of 91 cases.
You X; Dong Y; Wang J; Cheng Y; Jia Y; Zhang X; Wang J
BMC Cancer; 2024 Jan; 24(1):99. PubMed ID: 38233757
[TBL] [Abstract] [Full Text] [Related]
12. Impact of estrogen and progesterone receptor expression on the incidence of endometrial polyps.
Yan C; Xing C; Wei T; Zhou H; Wang H; Liu T; Gao J
Biomark Med; 2023 Nov; 17(21):881-887. PubMed ID: 38230984
[No Abstract] [Full Text] [Related]
13. Whether specific genetic feature predicted immunotherapy efficacy: A case report.
Chen J; Pang L; He L; Li T; Cheng X
Medicine (Baltimore); 2024 Jan; 103(2):e36922. PubMed ID: 38215117
[TBL] [Abstract] [Full Text] [Related]
14. Predictive and prognostic biomarkers in female genital tract tumours: an update highlighting their clinical relevance and practical issues.
Wong RW; Cheung ANY
Pathology; 2024 Mar; 56(2):214-227. PubMed ID: 38212229
[TBL] [Abstract] [Full Text] [Related]
15. Association between Serum Folate and Vaginal High-Risk Human Papillomavirus Infections in United States Women.
Peitz JG; Adebamowo CA; Adebamowo SN
J Nutr; 2024 Feb; 154(2):583-589. PubMed ID: 38158185
[TBL] [Abstract] [Full Text] [Related]
16. Oncologic, fertility, and obstetric outcomes with MPA therapy in women with endometrial cancer and atypical endometrial hyperplasia.
Takeda A; Yamamoto Y; Tamura K; Aoki H; Noguchi H; Minato S; Kamada S; Arakaki R; Kaji T; Iwasa T
J Obstet Gynaecol Res; 2024 Apr; 50(4):633-638. PubMed ID: 38154145
[TBL] [Abstract] [Full Text] [Related]
17. Cervical cancer screening in Brazilian Amazon Indigenous women: Towards the intensification of public policies for prevention.
Novais IR; Coelho CO; Machado HC; Surita F; Zeferino LC; Vale DB
PLoS One; 2023; 18(12):e0294956. PubMed ID: 38064494
[TBL] [Abstract] [Full Text] [Related]
18. Inflammatory cytokines and a diverse cervicovaginal microbiota associate with cervical dysplasia in a cohort of Hispanics living in Puerto Rico.
Tosado-Rodríguez E; Mendez LB; Espino AM; Dorta-Estremera S; Aquino EE; Romaguera J; Godoy-Vitorino F
PLoS One; 2023; 18(12):e0284673. PubMed ID: 38064478
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic Factors for uterine Sarcoma and Carcinosarcoma: Insights from a 10-Year Follow-Up Study.
Kotowicz B; Dańska-Bidzińska A; Fuksiewicz M; Nasierowska-Guttmejer A; Raczkiewicz D; Gujski M; Piątek S; Bidziński M
Med Sci Monit; 2023 Dec; 29():e941562. PubMed ID: 38058118
[TBL] [Abstract] [Full Text] [Related]
20. Results of a cluster randomized trial testing the Systems Analysis and Improvement Approach to increase cervical cancer screening in family planning clinics in Mombasa County, Kenya.
Eastment MC; Wanje G; Richardson BA; Mwaringa E; Patta S; Sherr K; Barnabas RV; Mandaliya K; Jaoko W; Mcclelland RS
Implement Sci; 2023 Nov; 18(1):66. PubMed ID: 38012647
[TBL] [Abstract] [Full Text] [Related]
[Next]
